BMO Capital Markets’s $30.3 target on RXO

RXO Rxo Inc

$28.6 → $30.3 (+6%) by Oct 2027

Market Perform · lowers · said Oct 6, 2026 · 12-month default horizon

Open: judged on the close on Oct 6, 2027

The article this target came from

BMO downgrades RXO stock rating on merger agreement terms

Investing.com · Oct 6, 2026

BMO Capital downgraded RXO, Inc. (NYSE:RXO) to Market Perform from Outperform and lowered its price target to $30.25 from $35.00.

BMO Capital Markets’s track record → Rxo Inc →

A fact about what BMO Capital Markets published, as reported by Investing.com, not a recommendation from Dalsna Finance; BMO Capital Markets is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.